Thyroid hormone activates fibroblast growth factor receptor-1 in bone

Molecular Endocrinology

Volumn 17, Issue 9, 2003, Pages 1751-1766

  Stevens, David A ^a   Harvey, Clare B ^a   Scott, Anthea J ^a   O'Shea, Patrick J ^a   Barnard, Joanna C ^a   Williams, Allan J ^a   Brady, Gerard ^b   Samarut, Jacques ^c   Chassande, Olivier ^c,d   Williams, Graham R ^a,e  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c Univ Claude Bernard   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; DOCKING PROTEIN; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PD 161570; PD 166866; PROTEIN INHIBITOR; THYROID HORMONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOPHOSPHORYLATION; BONE DEVELOPMENT; BONE DISEASE; DISEASE ASSOCIATION; FRAGILITY FRACTURE; GENE; GENE EXPRESSION; HYPERTHYROIDISM; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; RAT; THYROID DISEASE; TR ALPHA GENE;

ANIMALS; BONE AND BONES; FIBROBLAST GROWTH FACTOR 2; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOBLASTS; PHOSPHORYLATION; PHOSPHOTRANSFERASES; PYRIMIDINES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; THYROID GLAND; TRIIODOTHYRONINE; UREA;

ANIMALIA;

EID: 10744227966     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2003-0137     Document Type: Article

References (54)

1. Harvey CB, O'Shea PJ, Scott AJ, Robson H, Siebler T, Shalet SM, Samarut J, Chassande O, Williams GR 2002 Molecular mechanisms of thyroid hormone effects on bone growth and function. Mol Genet Metab 75:17-30
2. Reiter EO, Rosenfeld RG 1998 Normal and aberrant growth. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams textbook of endocrinology. Philadelphia: WB Saunders Co; 1427-1507
3. Rivkees SA, Bode HH, Crawford JD 1988 Long-term growth in juvenile acquired hypothyroidism: the failure to achieve normal adult stature. N Engl J Med 318:599-602
4. Weiss RE, Refetoff S 1996 Effect of thyroid hormone on growth. Lessons from the syndrome of resistance to thyroid hormone. Endocrinol Metab Clin North Am 25:719-730
5. Segni M, Leonardi E, Mazzoncini B, Pucarelli I, Pasquino AM 1999 Special features of Graves' disease in early childhood. Thyroid 9:871-877
6. Bauer DC, Ettinger B, Nevitt MC, Stone KL 2001 Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 134:561-568
7. Cummings SR, Browner WS, Bauer D, Stone K, Ensrud K, Jamal S, Ettinger B 1998 Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med 339:733-738
8. Mosekilde L, Eriksen EF, Charles P 1990 Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 19:35-63
9. Britto JM, Fenton AJ, Holloway WR, Nicholson GC 1994 Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology 134:169-176
10. Huang BK, Golden LA, Tarjan G, Madison LD, Stern PH 2000 Insulin-like growth factor I production is essential for anabolic effects of thyroid hormone in osteoblasts. J Bone Miner Res 15:188-197
11. Gouveia CH, Schultz J, Bianco AC, Brent GA 2001 Thyroid hormone stimulation of osteocalcin gene expression in ROS 17/2.8 cells is mediated by transcriptional and posttranscriptional mechanisms. J Endocrinol 170:667-675
12. Pereira RC, Jorgetti V, Canalis E 1999 Triiodothyronine induces collagenase-3 and gelatinase B expression in murine osteoblasts. Am J Physiol 277:E496-E504
13. Schmid C, Schlapfer I, Futo E, Waldvogel M, Schwander J, Zapf J, Froesch ER 1992 Triiodothyronine (T3) stimulates insulin-like growth factor (IGF)-1 and IGF binding protein (IGFBP)-2 production by rat osteoblasts in vitro. Acta Endocrinol (Copenh) 126:467-473
14. Glantschnig H, Varga F, Luegmayr E, Klaushofer K 1998 Characterization of the mouse insulin-like growth factor binding protein 4 gene regulatory region and expression studies. DNA Cell Biol 17:51-60
15. Siddiqi A, Burrin JM, Wood DF, Monson JP 1998 Triiodothyronine regulates the production of interleukin-6 and interleukin-8 in human bone marrow stromal and osteoblast-like cells. J Endocrinol 157:453-461
16. Yen PM 2001 Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097-1142
17. Stevens DA, Hasserjian RP, Robson H, Siebler T, Shalet SM, Williams GR 2000 Thyroid hormones regulate hypertrophic chondrocyte differentiation and expression of parathyroid hormone-related peptide and its receptor during endochondral bone formation. J Bone Miner Res 15:2431-2442
18. Krieger NS, Stappenbeck TS, Stern PH 1988 Characterization of specific thyroid hormone receptors in bone. J Bone Miner Res 3:473-478
19. Siddiqi A, Parsons MP, Lewis JL, Monson JP, Williams GR, Burrin JM 2002 TR expression and function in human bone marrow stromal and osteoblast-like cells. J Clin Endocrinol Metab 87:906-914
20. Robson H, Siebler T, Stevens DA, Shalet SM, Williams GR 2000 Thyroid hormone acts directly on growth plate chondrocytes to promote hypertrophic differentiation and inhibit clonal expansion and cell proliferation. Endocrinology 141:3887-3897
21. Gothe S, Wang Z, Ng L, Kindblom JM, Barros AC, Ohlsson C, Vennstrom B, Forrest D 1999 Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev 13:1329-1341
22. Gauthier K, Plateroti M, Harvey CB, Williams GR, Weiss RE, Refetoff S, Willott JF, Sundin V, Roux JP, Malaval L, Hara M, Samarut J, Chassande O 2001 Genetic analysis reveals different functions for the products of the thyroid hormone receptor α locus. Mol Cell Biol 21:4748-4760
23. Fraichard A, Chassande O, Plateroti M, Roux JP, Trouillas J, Dehay C, Legrand C, Gauthier K, Kedinger M, Malaval L, Rousset B, Samarut J 1997 The T3R α gene encoding a thyroid hormone receptor is essential for post-natal development and thyroid hormone production. EMBO J 16:4412-4420
24. Salto C, Kindblom JM, Johansson C, Wang Z, Gullberg H, Nordstrom K, Mansen A, Ohlsson C, Thoren P, Forrest D, Vennstrom B 2001 Ablation of TRα2 and a concomitant overexpression of α1 yields a mixed hypo- and hyperthyroid phenotype in mice. Mol Endocrinol 15:2115-2128
25. De Luca F, Baron J 1999 Control of bone growth by fibroblast Growth Factors. Trends Endocrinol Metab 10:61-65
26. Ornitz DM, Marie PJ 2002 FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16:1446-1465
27. Peters KG, Werner S, Chen G, Williams LT 1992 Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 114:233-243
28. Peters K, Ornitz D, Werner S, Williams L 1993 Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev Biol 155:423-430
29. Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, Pulleyn LJ, Rutland P, Reardon W, Malcolm S, Winter RM 1994 A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet 8:269-274
30. Wilkie AO, Morriss-Kay GM 2001 Genetics of craniofacial development and malformation. Nat Rev Genet 2:458-468
31. Schlessinger J 2000 Cell signaling by receptor tyrosine kinases. Cell 103:211-225
32. Shih A, Lin HY, Davis FB, Davis PJ 2001 Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase. Biochemistry 40:2870-2878
33. Lin HY, Davis FB, Gordinier JK, Martino LJ, Davis PJ 1999 Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells. Am J Physiol 276:C1014-C1024
34. Davis PJ, Shih A, Lin HY, Martino LJ, Davis FB 2000 Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR. J Biol Chem 275:38032-38039
35. Chien H-H, Lin W-L, Cho M-I 2000 Down-regulation of osteoblastic cell differentiation by epidermal growth factor receptor. Calcif Tissue Int 67:141-150
36. Chaudhary LR, Avioli LV 1997 Activation of extracellular signal-regulated kinases 1 and 2 (ERK1 and ERK2) by FGF-2 and PDGF-BB in normal human osteoblastic and bone marrow stromal cells: differences in mobility and in-gel renaturation of ERK1 in human, rat, and mouse osteoblastic cells. Biochem Biophys Res Commun 238:134-139
37. Chaudhary LR, Avioli LV 1998 Identification and activation of mitogen-activated protein (MAP) kinase in normal human osteoblastic and bone marrow stromal cells: attenuation of MAP kinase activation by cAMP, parathyroid hormone and forskolin. Mol Cell Biochem 178:59-68
38. Panek RL, Lu GH, Dahring TK, Batley BL, Connolly C, Hamby JM, Brown KJ 1998 In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase. J Pharmacol Exp Ther 286:569-577
39. Hamby JM, Connolly CJ, Schroeder MC, Winters RT, Showalter HD, Panek RL, Major TC, Olsewski B, Ryan MJ, Dahring T, Lu GH, Keiser J, Amar A, Shen C, Kraker AJ, Slintak V, Nelson JM, Fry DW, Bradford L, Hallak H, Doherty AM 1997 Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors. J Med Chem 40:2296-2303
40. Batley BL, Doherty AM, Hamby JM, Lu GH, Keller P, Dahring TK, Hwang O, Crickard K, Panek RL 1998 Inhibition of FGF-1 receptor tyrosine kinase activity by PD 161570, a new protein-tyrosine kinase inhibitor. Life Sci 62:143-150
41. Auboeuf D, Honig A, Berget SM, O'Malley BW 2002 Coordinate regulation of transcription and splicing by steroid receptor coregulators. Science 298:416-419
42. Hadari YR, Gotoh N, Kouhara H, Lax I, Schlessinger J 2001 Critical role for the docking protein FRS2α in FGF receptor-mediated signal transduction pathways. Proc Natl Acad Sci USA 98:8578-8583
43. Plotnikov AN, Hubbard SR, Schlessinger J, Mohammadi M 2000 Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell 101:413-424
44. Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A, Linhardt RJ, Mohammadi M 2000 Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell 6:743-750
45. Lai CF, Chaudhary L, Fausto A, Halstead LR, Ory DS, Avioli LV, Cheng SL 2001 Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 276:14443-14450
46. Greenwald JA, Mehrara BJ, Spector JA, Warren SM, Fagenholz PJ, Smith LE, Bouletreau PJ, Crisera FE, Ueno H, Longaker MT 2001 In vivo modulation of FGF biological activity alters cranial suture fate. Am J Pathol 158:441-452
47. Chen L, Adar R, Yang X, Monsonego EO, Li C, Hauschka PV, Yayon A, Deng CX 1999 Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J Clin Invest 104:1517-1525
48. Sahni M, Ambrosetti DC, Mansukhani A, Gertner R, Levy D, Basilico C 1999 FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev 13:1361-1366
49. 3, and retinoid signaling. Endocrinology 135:2375-2385
50. Shukunami C, Shigeno C, Atsumi T, Ishizeki K, Suzuki F, Hiraki Y 1996 Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor. J Cell Biol 133:457-468
51. Siebler T, Robson H, Shalet SM, Williams GR 2002 Dexamethasone inhibits and thyroid hormone promotes differentiation of mouse chondrogenic ATDC5 cells. Bone 31:457-464
52. Bellows CG, Aubin JE, Heersche JN, Antosz ME 1986 Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 38:143-154
53. Samuels HH, Stanley F, Casanova J 1979 Depletion of L-3,5,3′ -triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 105:80-85
54. Brady G, Iscove NN 1993 Construction of cDNA libraries from single cells. Methods Enzymol 225:611-623